• Sociocultural behavior changes, e.g. hand hygiene culture to be introduced into schools • National public health policy, e.g. ensured availability of water, improved sanitation and providing safe drinking water • To allocate more funds to develop public health infrastructure • Medical teachers MCI, NBE, universities to emphasize appropriate principles of antibiotic use in medical education at the under and postgraduate level • Drug policy should be made more streamlined and stringent, e.g. acceptable generic substitutions-by quality testing -Avoid irrational dual antibiotic combination -Ban over the counter (OTC) sales of schedule drugs.
• Hospital administrators should encourage:
-Antibiotic use policy in hospital-restriction through peer education and also aid in monitoring compliance to the policy -Step up hospital infection control • Regulatory bodies like NABH, NABL should seek active reporting of surveillance, and they must tighten norms for accreditation • Recertification and self-regulation by doctors through CME • Public awareness and public pledge-"Doctor, why are you prescribing me an antibiotic" campaign? • Societies and professional bodies like ASI, IMA should introduce a system of peer review to reduce antimicrobial overuse in the name of surgical prophylaxis • National will to change is essential and one must realize the fact that "No action today, no cure tomorrow". He also stressed the importance of responsible pharmaceutical promotion.
DR ARJUN SRINIVASAN, ASSOCIATE DIRECTOR FOR HEALTH CARE ASSOCIATED INFECTION PREVENTION PROGRAMS, CENTERS FOR DISEASE CONTROL AND PREVENTION
He suggested that there was an urgent need to improve laboratory detection, improve public health, laboratory infrastructure to detect new threats and perform reference testing to support clinical laboratories.
• Need for rapid communication within facilities and between facilities • Need to improve antibiotic use • Need for regional, interfacility collaboration • He also was of the opinion that an ongoing research, development and implementation of current and improved phenotypic and genotypic test methods for current pathogens was the need of the hour. 
INTRODUCTION

EUROPEAN INITIATIVES TO CONTROL ANTIBIOTIC USE AND RESISTANCE: HERMAN GOOSSENS, CHAIR OF THE TECHNICAL ADVISORY COMMITTEE OF THE EAAD (EUROPEAN ANTIBIOTIC AWARENESS DAY), ECDC (EUROPEAN CDC)
Why 
Control of Multidrug-Resistant Bacteria in Europe:
Stephan Harbarth, University of Geneva Hospitals 
APOCALYPSE DELAYED? LESSONS FROM ASIA: PAUL ANANTH TAMBYAH, NATIONAL UNIVERSITY OF SINGAPORE
Paul Ananth Tambyah discussed the special circumstances in Asian countries, to be considered, while formulating plans to tackle the resistance.
ROLE OF NATIONAL ACCREDITATION BOARD OF HOSPITALS IN TACKLING RESISTANCE-DR SANJEEV SINGH, MEMBER, TECHNICAL COMMITTEE AND CHAIRMAN, RESEARCH COMMITTEE, NABH
The following is the experience of NABH assessments: permitted to run the pharmacies. There should be no compromise about this • There should be credit points for regular orientation programs, which they should compulsorily attend • Above all, a strong legislation and the will power to execute this legislation are absolutely necessary and have to be undertaken very urgently.
Role of World Health Organization
• IMA and API other National Organizations should come forward to alert the Government system about this imminent problem of antibiotic resistance and the havoc it can cause if such measures are not undertaken immediately.
Opinion 2: Dr JA Jayalal, Honorary General Secretary IMA Tamil Nadu (IMA Representative)
Dr Jayalal did a detailed discussion on the background of the "National policy for containment of antimicrobial resistance" by the Department of Health and the fact that the policy was later held back by the health minister. Dr Jayalal stressed the importance of formulating a new national policy on containment of antimicrobial resistance, on urgent basis in order to rationalize antibiotic usage in the country. 
ROLE OF MICROBIOLOGY LABORATORY AND MICROBIOLOGISTS IN TACKLING ANTIMICROBIAL RESISTANCE: DR ARTI KAPIL, PROFESSOR, DEPARTMENT OF MICROBIOLOGY, AIIMS, NEW DELHI, INDIAN ASSOCIATION OF MEDICAL MICROBIOLOGISTS (IAMM) REPRESENTATIVE
Loop Holes in the System
• Accreditation of laboratories were voluntary, costly and without incentives • Limited infrastructure and facilities in most of the government hospital laboratories.
What Needs to Be Done?
• Microbiology laboratories need to be strengthened and microbiologist need to be proactive. 
Strengthen Antimicrobial-Resistance Monitoring
Referral Microbiology Laboratories
• Identify institutions in different regions as referral laboratories -Responsible for making a repository of the bacterial strains of interest/rare resistant markers -Undertake genotyping of the resistant isolates -Study emergence of new mechanism of resistance.
PANEL DISCUSSION 1
It was moderated by Dr HS Rissam, MCI representative.
Representatives of various medical societies, Dr Rama Kant (President, Association of Surgeons of India), Dr Ram E Rajagopalan (ISCCM), Dr Rajendrasing Pardeshi (FOGSI), Dr Raman Sardana (Hospital Infection Society), Dr A Muruganathan, President elect API and Dr JA Jayalal (IMA representative) participated in the discussion. There was a general consensus that urgent measures are needed to rationalize antibiotic usage in the country and medical societies will cooperate in all efforts toward this goal.
PANEL DISCUSSION 2
It was moderated by Professor B M Hegde, Former Vice Chancellor, Manipal Academy of Higher Education.
• Dr Siddharth N Shah, editor, JAPI stressed the role of journals in disseminating information on rational use of antibiotics.
• Dinesh C Sharma, Science editor, Mail Today, pointed out that medical journal should communicate with the press when articles of public health importance are published.
• Dr OC Abraham, Professor of Medicine, CMC Vellore conveyed the message that medical teachers can be role models to students in rational use of antibiotics and infection control practices. • Dr C Vamsathara, Director of Medical Education, Tamil Nadu stressed on the importance of training undergraduates and postgraduate medical students on rational use of antibiotics and infection control.
PANEL DISCUSSION 3
It was moderated by Dr PV Ramesh IAS, Principal Finance Secretary (R and E), Government of Andhra Pradesh.
• Mr S Manivannan, Deputy Drugs Controller General, enumerated DCGI plans to rationalize over the counter sale of antibiotics in the country.
• Dr JPS Gill, Professor and Head, Veterinary Public Health, GADVASU explained the importance of monitoring usage of antibiotics in the veterinary practice, for prophylactic, therapeutic and growth promoter purpose.
• Dr Subash Todi, Panel member of Ministry of Health expert committee STG on Critical Care discussed on the relevance of a special task group to formulate an antibiotic policy in the country.
